Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Safe Cosmetics and Personal Care Products Act of 2013
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 113th Please see additional page for lobbying issues:S. 1009, the Chemical Safety Improvement Act of 2013 The Breast Cancer Fund opposes this legislation in its current form as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 696, the Safe Chemicals Act of 2013 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 1385, the Safe Cosmetics and Personal Care Products Act of 2013 The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the CDCs environmental health grants programs and for NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
INNOCENCE PROJECT via THE RABEN GROUP
2014 · third_quarter · Q3
Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. H.R. 3064, the Forensic Science and Standards Act of 2013. S.2022, Forensic Science and Standards Act of 2014. S.2177, Criminal Justice and Forensic Science Reform Act.
Specific lobbying issues: Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. H.R. 3064, the Forensic Science and Standards Act of 2013. S.2022, Forensic Science and Standards Act of 2014. S.2177, Criminal Justice and Forensic Science Reform Act.Advocated for appropriations to support the expansion of forensic science research and standard-setting
Source: Senate LDA
Safe Cosmetics and Personal Care Products Act of 2013
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 113th Please see additional page for lobbying issues:S. 1009, the Chemical Safety Improvement Act of 2013 The Breast Cancer Fund opposes this legislation in its current form as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 696, the Safe Chemicals Act of 2013 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 1385, the Safe Cosmetics and Personal Care Products Act of 2013 The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the CDCs environmental health grants programs and for NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation.
Safe Cosmetics and Personal Care Products Act of 2013
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 113th Please see additional page for lobbying issues:S. 1009, the Chemical Safety Improvement Act of 2013 The Breast Cancer Fund opposes this legislation in its current form as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 696, the Safe Chemicals Act of 2013 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 1385, the Safe Cosmetics and Personal Care Products Act of 2013 The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the CDCs environmental health grants programs and for NIEHS programs related to breast cancer research. H.R.4435, National Defense Authorization Act for FY2015 (NDAA) The Breast Cancer Fund supports an amendment to NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). S.2410, National Defense Authorization Act for FY2015 (NDAA) The Breast Cancer Fund supports an amendment to NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts.Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation.
Forensic Science and Standards Act of 2013
Client: INNOCENCE PROJECT · Firm: THE RABEN GROUP
Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. H.R. 3064, the Forensic Science and Standards Act of 2013. S.2022, Forensic Science and Standards Act of 2014. S.2177, Criminal Justice and Forensic Science Reform Act.
Forensic Science and Standards Act of 2013
Client: INNOCENCE PROJECT · Firm: THE RABEN GROUP
Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. H.R. 3064, the Forensic Science and Standards Act of 2013. S.2022, Forensic Science and Standards Act of 2014. S.2177, Criminal Justice and Forensic Science Reform Act.
Forensic Science and Standards Act of 2013
Client: INNOCENCE PROJECT · Firm: THE RABEN GROUP
Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. H.R. 3064, the Forensic Science and Standards Act of 2013. S.2022, Forensic Science and Standards Act of 2014. S.2177, Criminal Justice and Forensic Science Reform Act.
Forensic Science and Standards Act of 2013
Client: INNOCENCE PROJECT · Firm: THE RABEN GROUP
Specific lobbying issues: Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. H.R. 3064, the Forensic Science and Standards Act of 2013. S.2022, Forensic Science and Standards Act of 2014. S.2177, Criminal Justice and Forensic Science Reform Act.Advocated for appropriations to support the expansion of forensic science research and standard-setting
Forensic Science and Standards Act of 2013
Client: INNOCENCE PROJECT · Firm: THE RABEN GROUP
Specific lobbying issues: Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. H.R. 3064, the Forensic Science and Standards Act of 2013. S.2022, Forensic Science and Standards Act of 2014. S.2177, Criminal Justice and Forensic Science Reform Act.Advocated for appropriations to support the expansion of forensic science research and standard-setting
Forensic Science and Standards Act of 2013
Client: INNOCENCE PROJECT · Firm: THE RABEN GROUP
Specific lobbying issues: Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. H.R. 3064, the Forensic Science and Standards Act of 2013. S.2022, Forensic Science and Standards Act of 2014. S.2177, Criminal Justice and Forensic Science Reform Act.Advocated for appropriations to support the expansion of forensic science research and standard-setting
Expressing the sense of the House of Representatives that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
Expressing the sense of the House of Representatives that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
Expressing the sense of the House of Representatives that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
Expressing the sense of the House of Representatives that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
Expressing the sense of the House of Representatives that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
Expressing the sense of the House of Representatives that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
Expressing the sense of the House of Representatives that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
Expressing the sense of the House of Representatives that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
Expressing the sense of the House of Representatives that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
Expressing the sense of the House of Representatives that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
Expressing the sense of the House of Representatives that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
Expressing the sense of the House of Representatives that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
Chemical Safety Improvement Act
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 113th Please see additional page for lobbying issues:S. 1009, the Chemical Safety Improvement Act of 2013 The Breast Cancer Fund opposes this legislation in its current form as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 696, the Safe Chemicals Act of 2013 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 1385, the Safe Cosmetics and Personal Care Products Act of 2013 The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the CDCs environmental health grants programs and for NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation.
Chemical Safety Improvement Act
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 113th Please see additional page for lobbying issues:S. 1009, the Chemical Safety Improvement Act of 2013 The Breast Cancer Fund opposes this legislation in its current form as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 696, the Safe Chemicals Act of 2013 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 1385, the Safe Cosmetics and Personal Care Products Act of 2013 The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the CDCs environmental health grants programs and for NIEHS programs related to breast cancer research. H.R.4435, National Defense Authorization Act for FY2015 (NDAA) The Breast Cancer Fund supports an amendment to NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). S.2410, National Defense Authorization Act for FY2015 (NDAA) The Breast Cancer Fund supports an amendment to NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts.Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation.
Chemical Safety Improvement Act
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 113th Please see additional page for lobbying issues:S. 1009, the Chemical Safety Improvement Act of 2013 The Breast Cancer Fund opposes this legislation in its current form as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 696, the Safe Chemicals Act of 2013 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 1385, the Safe Cosmetics and Personal Care Products Act of 2013 The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the CDCs environmental health grants programs and for NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation.
Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. H.R. 3064, the Forensic Science and Standards Act of 2013. S.2022, Forensic Science and Standards Act of 2014. S.2177, Criminal Justice and Forensic Science Reform Act.
Specific lobbying issues: Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. H.R. 3064, the Forensic Science and Standards Act of 2013. S.2022, Forensic Science and Standards Act of 2014. S.2177, Criminal Justice and Forensic Science Reform Act.Advocated for appropriations to support the expansion of forensic science research and standard-setting
Specific lobbying issues: Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. H.R. 3064, the Forensic Science and Standards Act of 2013. S.2022, Forensic Science and Standards Act of 2014. S.2177, Criminal Justice and Forensic Science Reform Act.Advocated for appropriations to support the expansion of forensic science research and standard-setting
Specific lobbying issues: Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. H.R. 3064, the Forensic Science and Standards Act of 2013. S.2022, Forensic Science and Standards Act of 2014. S.2177, Criminal Justice and Forensic Science Reform Act.Advocated for appropriations to support the expansion of forensic science research and standard-setting
Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. H.R. 3064, the Forensic Science and Standards Act of 2013. S.2022, Forensic Science and Standards Act of 2014. S.2177, Criminal Justice and Forensic Science Reform Act.
Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. H.R. 3064, the Forensic Science and Standards Act of 2013. S.2022, Forensic Science and Standards Act of 2014. S.2177, Criminal Justice and Forensic Science Reform Act.
Criminal Justice and Forensic Science Reform Act
Client: INNOCENCE PROJECT · Firm: THE RABEN GROUP
Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. H.R. 3064, the Forensic Science and Standards Act of 2013. S.2022, Forensic Science and Standards Act of 2014. S.2177, Criminal Justice and Forensic Science Reform Act.
Criminal Justice and Forensic Science Reform Act
Client: INNOCENCE PROJECT · Firm: THE RABEN GROUP
Specific lobbying issues: Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. H.R. 3064, the Forensic Science and Standards Act of 2013. S.2022, Forensic Science and Standards Act of 2014. S.2177, Criminal Justice and Forensic Science Reform Act.Advocated for appropriations to support the expansion of forensic science research and standard-setting
Criminal Justice and Forensic Science Reform Act
Client: INNOCENCE PROJECT · Firm: THE RABEN GROUP
Specific lobbying issues: Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. H.R. 3064, the Forensic Science and Standards Act of 2013. S.2022, Forensic Science and Standards Act of 2014. S.2177, Criminal Justice and Forensic Science Reform Act.Advocated for appropriations to support the expansion of forensic science research and standard-setting
Criminal Justice and Forensic Science Reform Act
Client: INNOCENCE PROJECT · Firm: THE RABEN GROUP
Specific lobbying issues: Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. H.R. 3064, the Forensic Science and Standards Act of 2013. S.2022, Forensic Science and Standards Act of 2014. S.2177, Criminal Justice and Forensic Science Reform Act.Advocated for appropriations to support the expansion of forensic science research and standard-setting
Criminal Justice and Forensic Science Reform Act
Client: INNOCENCE PROJECT · Firm: THE RABEN GROUP
Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. H.R. 3064, the Forensic Science and Standards Act of 2013. S.2022, Forensic Science and Standards Act of 2014. S.2177, Criminal Justice and Forensic Science Reform Act.
Criminal Justice and Forensic Science Reform Act
Client: INNOCENCE PROJECT · Firm: THE RABEN GROUP
Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. H.R. 3064, the Forensic Science and Standards Act of 2013. S.2022, Forensic Science and Standards Act of 2014. S.2177, Criminal Justice and Forensic Science Reform Act.
Safe Chemicals Act of 2013
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 113th Please see additional page for lobbying issues:S. 1009, the Chemical Safety Improvement Act of 2013 The Breast Cancer Fund opposes this legislation in its current form as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 696, the Safe Chemicals Act of 2013 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 1385, the Safe Cosmetics and Personal Care Products Act of 2013 The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the CDCs environmental health grants programs and for NIEHS programs related to breast cancer research. H.R.4435, National Defense Authorization Act for FY2015 (NDAA) The Breast Cancer Fund supports an amendment to NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). S.2410, National Defense Authorization Act for FY2015 (NDAA) The Breast Cancer Fund supports an amendment to NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts.Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation.
Safe Chemicals Act of 2013
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 113th Please see additional page for lobbying issues:S. 1009, the Chemical Safety Improvement Act of 2013 The Breast Cancer Fund opposes this legislation in its current form as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 696, the Safe Chemicals Act of 2013 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 1385, the Safe Cosmetics and Personal Care Products Act of 2013 The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the CDCs environmental health grants programs and for NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation.
Safe Chemicals Act of 2013
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 113th Please see additional page for lobbying issues:S. 1009, the Chemical Safety Improvement Act of 2013 The Breast Cancer Fund opposes this legislation in its current form as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 696, the Safe Chemicals Act of 2013 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 1385, the Safe Cosmetics and Personal Care Products Act of 2013 The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the CDCs environmental health grants programs and for NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation.
A resolution expressing the sense of the Senate that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
A resolution expressing the sense of the Senate that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
A resolution expressing the sense of the Senate that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
A resolution expressing the sense of the Senate that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
A resolution expressing the sense of the Senate that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
A resolution expressing the sense of the Senate that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
A resolution expressing the sense of the Senate that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
A resolution expressing the sense of the Senate that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
A resolution expressing the sense of the Senate that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
A resolution expressing the sense of the Senate that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
A resolution expressing the sense of the Senate that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
A resolution expressing the sense of the Senate that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
A bill to extend the temporary suspension of duty on 1,3-Benzenedicarboxamide, N, N'-bis-(2,2,6,6-tetramethyl-4-piperidinyl)-.
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 113th Please see additional page for lobbying issues:S. 1009, the Chemical Safety Improvement Act of 2013 The Breast Cancer Fund opposes this legislation in its current form as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 696, the Safe Chemicals Act of 2013 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 1385, the Safe Cosmetics and Personal Care Products Act of 2013 The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the CDCs environmental health grants programs and for NIEHS programs related to breast cancer research. H.R.4435, National Defense Authorization Act for FY2015 (NDAA) The Breast Cancer Fund supports an amendment to NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). S.2410, National Defense Authorization Act for FY2015 (NDAA) The Breast Cancer Fund supports an amendment to NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts.Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation.
Safe Cosmetics and Personal Care Products Act of 2013
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 113th Please see additional page for lobbying issues:S. 1009, the Chemical Safety Improvement Act of 2013 The Breast Cancer Fund opposes this legislation in its current form as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 696, the Safe Chemicals Act of 2013 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 1385, the Safe Cosmetics and Personal Care Products Act of 2013 The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program, and increasing support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation.
Safe Cosmetics and Personal Care Products Act of 2013
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 113th Please see additional page for lobbying issues:S. 1009, the Chemical Safety Improvement Act of 2013 The Breast Cancer Fund opposes this legislation in its current form as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 696, the Safe Chemicals Act of 2013 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 1385, the Safe Cosmetics and Personal Care Products Act of 2013 The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program, and increasing support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation.
Safe Cosmetics and Personal Care Products Act of 2013
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 113th Please see additional page for lobbying issues:S. 696, the Safe Chemicals Act of 2013 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 1385, the Safe Cosmetics and Personal Care Products Act of 2013 The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program, and increasing support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation.
Safe Cosmetics and Personal Care Products Act of 2013
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 113th Please see additional page for lobbying issues:S. 696, the Safe Chemicals Act of 2013 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 1385, the Safe Cosmetics and Personal Care Products Act of 2013 The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program, and increasing support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation.
Forensic Science and Standards Act of 2013
Client: INNOCENCE PROJECT · Firm: THE RABEN GROUP
Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. H.R. 3064, the Forensic Science and Standards Act of 2013.
Forensic Science and Standards Act of 2013
Client: INNOCENCE PROJECT · Firm: THE RABEN GROUP
Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. H.R. 3064, the Forensic Science and Standards Act of 2013.
Expressing the sense of the House of Representatives that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
Expressing the sense of the House of Representatives that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
Expressing the sense of the House of Representatives that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
Expressing the sense of the House of Representatives that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
Expressing the sense of the House of Representatives that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
Expressing the sense of the House of Representatives that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
Expressing the sense of the House of Representatives that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
Expressing the sense of the House of Representatives that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
Expressing the sense of the House of Representatives that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
Expressing the sense of the House of Representatives that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
Expressing the sense of the House of Representatives that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
Expressing the sense of the House of Representatives that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
Chemical Safety Improvement Act
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 113th Please see additional page for lobbying issues:S. 1009, the Chemical Safety Improvement Act of 2013 The Breast Cancer Fund opposes this legislation in its current form as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 696, the Safe Chemicals Act of 2013 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 1385, the Safe Cosmetics and Personal Care Products Act of 2013 The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program, and increasing support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation.
Chemical Safety Improvement Act
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 113th Please see additional page for lobbying issues:S. 1009, the Chemical Safety Improvement Act of 2013 The Breast Cancer Fund opposes this legislation in its current form as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 696, the Safe Chemicals Act of 2013 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 1385, the Safe Cosmetics and Personal Care Products Act of 2013 The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program, and increasing support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation.
Safe Chemicals Act of 2013
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 113th Please see additional page for lobbying issues:S. 1009, the Chemical Safety Improvement Act of 2013 The Breast Cancer Fund opposes this legislation in its current form as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 696, the Safe Chemicals Act of 2013 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 1385, the Safe Cosmetics and Personal Care Products Act of 2013 The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program, and increasing support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation.
Safe Chemicals Act of 2013
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 113th Please see additional page for lobbying issues:S. 696, the Safe Chemicals Act of 2013 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 1385, the Safe Cosmetics and Personal Care Products Act of 2013 The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program, and increasing support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation.
Safe Chemicals Act of 2013
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 113th Please see additional page for lobbying issues:S. 696, the Safe Chemicals Act of 2013 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 1385, the Safe Cosmetics and Personal Care Products Act of 2013 The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program, and increasing support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation.
Safe Chemicals Act of 2013
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 113th Please see additional page for lobbying issues:S. 1009, the Chemical Safety Improvement Act of 2013 The Breast Cancer Fund opposes this legislation in its current form as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 696, the Safe Chemicals Act of 2013 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 1385, the Safe Cosmetics and Personal Care Products Act of 2013 The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program, and increasing support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation.
A resolution expressing the sense of the Senate that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
A resolution expressing the sense of the Senate that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
A resolution expressing the sense of the Senate that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
A resolution expressing the sense of the Senate that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
A resolution expressing the sense of the Senate that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
A resolution expressing the sense of the Senate that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
A resolution expressing the sense of the Senate that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
A resolution expressing the sense of the Senate that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
A resolution expressing the sense of the Senate that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
A resolution expressing the sense of the Senate that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
A resolution expressing the sense of the Senate that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
A resolution expressing the sense of the Senate that supporting seniors and individuals with disabilities is an important responsibility of the United States, and that a comprehensive approach to expanding and supporting a strong home care workforce and making long-term services and supports affordable and accessible in communities is necessary to uphold the right of seniors and individuals with disabilities in the United States to a dignified quality of life.
Client: JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE · Firm: THE RABEN GROUP
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
Forensic Science and Standards Act of 2012
Client: INNOCENCE PROJECT · Firm: THE RABEN GROUP
Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. The Criminal Justice and Forensic Science Reform Act of 2011, S.132. The Forensic Science and Standards Act of 2012, S.3378/H.R.6106.
Enhancing CPSC Authority and Discretion Act of 2011
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 112th H.R. 432, the Ban Poisonous Additives Act of 2011( related Senate Bill, S. 136) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. Continued: Legislation in the 112th S. 847, the Safe Chemicals Act of 2011 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 2359, the Safe Cosmetics Act of 2011 The Breast Cancer Fund supports this legislation to reform the FDA's regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. H.R. 2521, the Endocrine-Disrupting Chemicals Exposure Elimination act of 2011 (Senate version S. 1361) and H.R. 553 Endocrine Disruptor Screening Enhancement Act of 2011 The Breast Cancer Fund supported this legislation as it would increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. H.R. 1939: Enhancing CPSC Authority and Discretion Act of 2011. The Breast Cancer Fund lobbied for a provision that ensures that phthalates, when necessary in the manufacture of children's toys, are only used safely. H.R. 3067: Accelerating the End of Breast Cancer Act of 2011. The Breast Cancer Fund supported this legislation as it would increase focus on research to prevent, treat, and end breast caner. House and Senate Appropriations - The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program as well as support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various House and Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. Presidents Cancer Panel Report The Breast Cancer Fund communicated with staff in the Executive Office of the President and the Office of Science and Technology Policy regarding the report and recommendations of the President's Cancer Panel, and continues to encourage ongoing efforts by the Executive Branch to raise awareness about breast cancer risk, prevention, and the environment. P.L. 110-314 - The Consumer Product Safety Commission Inprovement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of children's toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and are submitting public comments at various stages of the law's implementation. P.L. 110-354 - Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.
Enhancing CPSC Authority and Discretion Act of 2011
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 112th H.R. 432, the Ban Poisonous Additives Act of 2011( related Senate Bill, S. 136) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. Continued: Legislation in the 112th S. 847, the Safe Chemicals Act of 2011 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 2359, the Safe Cosmetics Act of 2011 The Breast Cancer Fund supports this legislation to reform the FDA's regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. H.R.4395, the Cosmetic Safety Amendments Act of 2012 The Breast Cancer Fund opposes this legislation as it would further weaken the FDAs ability to regulate the safety of cosmetics. H.R. 4262, the Cosmetics Safety Enhancement Act of 2012 The Breast Cancer Fund opposes this legislation as it is not strong enough to effectively regulate the safety of cosmetics. H.R. 2521, the Endocrine-Disrupting Chemicals Exposure Elimination act of 2011 (Senate version S. 1361) and H.R. 553 Endocrine Disruptor Screening Enhancement Act of 2011 The Breast Cancer Fund supported this legislation as it would increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. H.R. 1939: Enhancing CPSC Authority and Discretion Act of 2011. The Breast Cancer Fund lobbied for a provision that ensures that phthalates, when necessary in the manufacture of children's toys, are only used safely. H.R. 3067: Accelerating the End of Breast Cancer Act of 2011. The Breast Cancer Fund supported this legislation as it would increase focus on research to prevent, treat, and end breast caner. S. 3237, the Accelerating the End of Breast Cancer Act of 2012. The Breast Cancer Fund supports this legislation as it would increase focus on research to prevent, treat, and end breast cancer. House and Senate Appropriations - The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program, opposing appropriations riders limiting the work of the National Toxicology Program's Report on Carcinogens, and increasing support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various House and Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. Presidents Cancer Panel Report The Breast Cancer Fund communicated with staff in the Executive Office of the President and the Office of Science and Technology Policy regarding the report and recommendations of the President's Cancer Panel, and continues to encourage ongoing efforts by the Executive Branch to raise awareness about breast cancer risk, prevention, and the environment. P.L. 110-314 - The Consumer Product Safety Commission Inprovement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of children's toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and are submitting public comments at various stages of the law's implementation. P.L. 110-354 - Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.
Enhancing CPSC Authority and Discretion Act of 2011
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 112th H.R. 432, the Ban Poisonous Additives Act of 2011( related Senate Bill, S. 136) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. Continued: Legislation in the 112th S. 847, the Safe Chemicals Act of 2011 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 2359, the Safe Cosmetics Act of 2011 The Breast Cancer Fund supports this legislation to reform the FDA's regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. H.R.4395, the Cosmetic Safety Amendments Act of 2012 The Breast Cancer Fund opposes this legislation as it would further weaken the FDAs ability to regulate the safety of cosmetics. H.R. 4262, the Cosmetics Safety Enhancement Act of 2012 The Breast Cancer Fund opposes this legislation as it is not strong enough to effectively regulate the safety of cosmetics. H.R. 2521, the Endocrine-Disrupting Chemicals Exposure Elimination act of 2011 (Senate version S. 1361) and H.R. 553 Endocrine Disruptor Screening Enhancement Act of 2011 The Breast Cancer Fund supported this legislation as it would increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. H.R. 1939: Enhancing CPSC Authority and Discretion Act of 2011. The Breast Cancer Fund lobbied for a provision that ensures that phthalates, when necessary in the manufacture of children's toys, are only used safely. H.R. 3067: Accelerating the End of Breast Cancer Act of 2011. The Breast Cancer Fund supported this legislation as it would increase focus on research to prevent, treat, and end breast caner. S. 3237, the Accelerating the End of Breast Cancer Act of 2012. The Breast Cancer Fund supports this legislation as it would increase focus on research to prevent, treat, and end breast cancer. House and Senate Appropriations - The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program as well as support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various House and Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. Presidents Cancer Panel Report The Breast Cancer Fund communicated with staff in the Executive Office of the President and the Office of Science and Technology Policy regarding the report and recommendations of the President's Cancer Panel, and continues to encourage ongoing efforts by the Executive Branch to raise awareness about breast cancer risk, prevention, and the environment. P.L. 110-314 - The Consumer Product Safety Commission Inprovement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of children's toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and are submitting public comments at various stages of the law's implementation. P.L. 110-354 - Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.
Enhancing CPSC Authority and Discretion Act of 2011
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 112th H.R. 432, the Ban Poisonous Additives Act of 2011( related Senate Bill, S. 136) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. Continued: Legislation in the 112th S. 847, the Safe Chemicals Act of 2011 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 2359, the Safe Cosmetics Act of 2011 The Breast Cancer Fund supports this legislation to reform the FDA's regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. H.R.4395, the Cosmetic Safety Amendments Act of 2012 The Breast Cancer Fund opposes this legislation as it would further weaken the FDAs ability to regulate the safety of cosmetics. H.R. 4262, the Cosmetics Safety Enhancement Act of 2012 The Breast Cancer Fund opposes this legislation as it is not strong enough to effectively regulate the safety of cosmetics. H.R. 2521, the Endocrine-Disrupting Chemicals Exposure Elimination act of 2011 (Senate version S. 1361) and H.R. 553 Endocrine Disruptor Screening Enhancement Act of 2011 The Breast Cancer Fund supported this legislation as it would increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. H.R. 1939: Enhancing CPSC Authority and Discretion Act of 2011. The Breast Cancer Fund lobbied for a provision that ensures that phthalates, when necessary in the manufacture of children's toys, are only used safely. H.R. 3067: Accelerating the End of Breast Cancer Act of 2011. The Breast Cancer Fund supported this legislation as it would increase focus on research to prevent, treat, and end breast caner. S. 3237, the Accelerating the End of Breast Cancer Act of 2012. The Breast Cancer Fund supports this legislation as it would increase focus on research to prevent, treat, and end breast cancer. House and Senate Appropriations - The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program, opposing appropriations riders limiting the work of the National Toxicology Program's Report on Carcinogens, and increasing support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various House and Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. Presidents Cancer Panel Report The Breast Cancer Fund communicated with staff in the Executive Office of the President and the Office of Science and Technology Policy regarding the report and recommendations of the President's Cancer Panel, and continues to encourage ongoing efforts by the Executive Branch to raise awareness about breast cancer risk, prevention, and the environment. P.L. 110-314 - The Consumer Product Safety Commission Inprovement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of children's toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and are submitting public comments at various stages of the law's implementation. P.L. 110-354 - Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.
Safe Cosmetics Act of 2011
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 112th H.R. 432, the Ban Poisonous Additives Act of 2011( related Senate Bill, S. 136) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. Continued: Legislation in the 112th S. 847, the Safe Chemicals Act of 2011 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 2359, the Safe Cosmetics Act of 2011 The Breast Cancer Fund supports this legislation to reform the FDA's regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. H.R.4395, the Cosmetic Safety Amendments Act of 2012 The Breast Cancer Fund opposes this legislation as it would further weaken the FDAs ability to regulate the safety of cosmetics. H.R. 4262, the Cosmetics Safety Enhancement Act of 2012 The Breast Cancer Fund opposes this legislation as it is not strong enough to effectively regulate the safety of cosmetics. H.R. 2521, the Endocrine-Disrupting Chemicals Exposure Elimination act of 2011 (Senate version S. 1361) and H.R. 553 Endocrine Disruptor Screening Enhancement Act of 2011 The Breast Cancer Fund supported this legislation as it would increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. H.R. 1939: Enhancing CPSC Authority and Discretion Act of 2011. The Breast Cancer Fund lobbied for a provision that ensures that phthalates, when necessary in the manufacture of children's toys, are only used safely. H.R. 3067: Accelerating the End of Breast Cancer Act of 2011. The Breast Cancer Fund supported this legislation as it would increase focus on research to prevent, treat, and end breast caner. S. 3237, the Accelerating the End of Breast Cancer Act of 2012. The Breast Cancer Fund supports this legislation as it would increase focus on research to prevent, treat, and end breast cancer. House and Senate Appropriations - The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program, opposing appropriations riders limiting the work of the National Toxicology Program's Report on Carcinogens, and increasing support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various House and Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. Presidents Cancer Panel Report The Breast Cancer Fund communicated with staff in the Executive Office of the President and the Office of Science and Technology Policy regarding the report and recommendations of the President's Cancer Panel, and continues to encourage ongoing efforts by the Executive Branch to raise awareness about breast cancer risk, prevention, and the environment. P.L. 110-314 - The Consumer Product Safety Commission Inprovement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of children's toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and are submitting public comments at various stages of the law's implementation. P.L. 110-354 - Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.
Safe Cosmetics Act of 2011
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 112th H.R. 432, the Ban Poisonous Additives Act of 2011( related Senate Bill, S. 136) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. Continued: Legislation in the 112th S. 847, the Safe Chemicals Act of 2011 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 2359, the Safe Cosmetics Act of 2011 The Breast Cancer Fund supports this legislation to reform the FDA's regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. H.R.4395, the Cosmetic Safety Amendments Act of 2012 The Breast Cancer Fund opposes this legislation as it would further weaken the FDAs ability to regulate the safety of cosmetics. H.R. 4262, the Cosmetics Safety Enhancement Act of 2012 The Breast Cancer Fund opposes this legislation as it is not strong enough to effectively regulate the safety of cosmetics. H.R. 2521, the Endocrine-Disrupting Chemicals Exposure Elimination act of 2011 (Senate version S. 1361) and H.R. 553 Endocrine Disruptor Screening Enhancement Act of 2011 The Breast Cancer Fund supported this legislation as it would increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. H.R. 1939: Enhancing CPSC Authority and Discretion Act of 2011. The Breast Cancer Fund lobbied for a provision that ensures that phthalates, when necessary in the manufacture of children's toys, are only used safely. H.R. 3067: Accelerating the End of Breast Cancer Act of 2011. The Breast Cancer Fund supported this legislation as it would increase focus on research to prevent, treat, and end breast caner. S. 3237, the Accelerating the End of Breast Cancer Act of 2012. The Breast Cancer Fund supports this legislation as it would increase focus on research to prevent, treat, and end breast cancer. House and Senate Appropriations - The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program, opposing appropriations riders limiting the work of the National Toxicology Program's Report on Carcinogens, and increasing support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various House and Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. Presidents Cancer Panel Report The Breast Cancer Fund communicated with staff in the Executive Office of the President and the Office of Science and Technology Policy regarding the report and recommendations of the President's Cancer Panel, and continues to encourage ongoing efforts by the Executive Branch to raise awareness about breast cancer risk, prevention, and the environment. P.L. 110-314 - The Consumer Product Safety Commission Inprovement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of children's toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and are submitting public comments at various stages of the law's implementation. P.L. 110-354 - Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.
Safe Cosmetics Act of 2011
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 112th H.R. 432, the Ban Poisonous Additives Act of 2011( related Senate Bill, S. 136) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. Continued: Legislation in the 112th S. 847, the Safe Chemicals Act of 2011 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 2359, the Safe Cosmetics Act of 2011 The Breast Cancer Fund supports this legislation to reform the FDA's regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. H.R.4395, the Cosmetic Safety Amendments Act of 2012 The Breast Cancer Fund opposes this legislation as it would further weaken the FDAs ability to regulate the safety of cosmetics. H.R. 4262, the Cosmetics Safety Enhancement Act of 2012 The Breast Cancer Fund opposes this legislation as it is not strong enough to effectively regulate the safety of cosmetics. H.R. 2521, the Endocrine-Disrupting Chemicals Exposure Elimination act of 2011 (Senate version S. 1361) and H.R. 553 Endocrine Disruptor Screening Enhancement Act of 2011 The Breast Cancer Fund supported this legislation as it would increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. H.R. 1939: Enhancing CPSC Authority and Discretion Act of 2011. The Breast Cancer Fund lobbied for a provision that ensures that phthalates, when necessary in the manufacture of children's toys, are only used safely. H.R. 3067: Accelerating the End of Breast Cancer Act of 2011. The Breast Cancer Fund supported this legislation as it would increase focus on research to prevent, treat, and end breast caner. S. 3237, the Accelerating the End of Breast Cancer Act of 2012. The Breast Cancer Fund supports this legislation as it would increase focus on research to prevent, treat, and end breast cancer. House and Senate Appropriations - The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program as well as support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various House and Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. Presidents Cancer Panel Report The Breast Cancer Fund communicated with staff in the Executive Office of the President and the Office of Science and Technology Policy regarding the report and recommendations of the President's Cancer Panel, and continues to encourage ongoing efforts by the Executive Branch to raise awareness about breast cancer risk, prevention, and the environment. P.L. 110-314 - The Consumer Product Safety Commission Inprovement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of children's toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and are submitting public comments at various stages of the law's implementation. P.L. 110-354 - Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.
Safe Cosmetics Act of 2011
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 112th H.R. 432, the Ban Poisonous Additives Act of 2011( related Senate Bill, S. 136) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. Continued: Legislation in the 112th S. 847, the Safe Chemicals Act of 2011 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 2359, the Safe Cosmetics Act of 2011 The Breast Cancer Fund supports this legislation to reform the FDA's regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. H.R. 2521, the Endocrine-Disrupting Chemicals Exposure Elimination act of 2011 (Senate version S. 1361) and H.R. 553 Endocrine Disruptor Screening Enhancement Act of 2011 The Breast Cancer Fund supported this legislation as it would increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. H.R. 1939: Enhancing CPSC Authority and Discretion Act of 2011. The Breast Cancer Fund lobbied for a provision that ensures that phthalates, when necessary in the manufacture of children's toys, are only used safely. H.R. 3067: Accelerating the End of Breast Cancer Act of 2011. The Breast Cancer Fund supported this legislation as it would increase focus on research to prevent, treat, and end breast caner. House and Senate Appropriations - The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program as well as support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various House and Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. Presidents Cancer Panel Report The Breast Cancer Fund communicated with staff in the Executive Office of the President and the Office of Science and Technology Policy regarding the report and recommendations of the President's Cancer Panel, and continues to encourage ongoing efforts by the Executive Branch to raise awareness about breast cancer risk, prevention, and the environment. P.L. 110-314 - The Consumer Product Safety Commission Inprovement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of children's toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and are submitting public comments at various stages of the law's implementation. P.L. 110-354 - Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.
Endocrine-Disrupting Chemicals Exposure Elimination Act of 2011
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 112th H.R. 432, the Ban Poisonous Additives Act of 2011( related Senate Bill, S. 136) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. Continued: Legislation in the 112th S. 847, the Safe Chemicals Act of 2011 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 2359, the Safe Cosmetics Act of 2011 The Breast Cancer Fund supports this legislation to reform the FDA's regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. H.R. 2521, the Endocrine-Disrupting Chemicals Exposure Elimination act of 2011 (Senate version S. 1361) and H.R. 553 Endocrine Disruptor Screening Enhancement Act of 2011 The Breast Cancer Fund supported this legislation as it would increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. H.R. 1939: Enhancing CPSC Authority and Discretion Act of 2011. The Breast Cancer Fund lobbied for a provision that ensures that phthalates, when necessary in the manufacture of children's toys, are only used safely. H.R. 3067: Accelerating the End of Breast Cancer Act of 2011. The Breast Cancer Fund supported this legislation as it would increase focus on research to prevent, treat, and end breast caner. House and Senate Appropriations - The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program as well as support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various House and Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. Presidents Cancer Panel Report The Breast Cancer Fund communicated with staff in the Executive Office of the President and the Office of Science and Technology Policy regarding the report and recommendations of the President's Cancer Panel, and continues to encourage ongoing efforts by the Executive Branch to raise awareness about breast cancer risk, prevention, and the environment. P.L. 110-314 - The Consumer Product Safety Commission Inprovement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of children's toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and are submitting public comments at various stages of the law's implementation. P.L. 110-354 - Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.
Endocrine-Disrupting Chemicals Exposure Elimination Act of 2011
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 112th H.R. 432, the Ban Poisonous Additives Act of 2011( related Senate Bill, S. 136) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. Continued: Legislation in the 112th S. 847, the Safe Chemicals Act of 2011 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 2359, the Safe Cosmetics Act of 2011 The Breast Cancer Fund supports this legislation to reform the FDA's regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. H.R.4395, the Cosmetic Safety Amendments Act of 2012 The Breast Cancer Fund opposes this legislation as it would further weaken the FDAs ability to regulate the safety of cosmetics. H.R. 4262, the Cosmetics Safety Enhancement Act of 2012 The Breast Cancer Fund opposes this legislation as it is not strong enough to effectively regulate the safety of cosmetics. H.R. 2521, the Endocrine-Disrupting Chemicals Exposure Elimination act of 2011 (Senate version S. 1361) and H.R. 553 Endocrine Disruptor Screening Enhancement Act of 2011 The Breast Cancer Fund supported this legislation as it would increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. H.R. 1939: Enhancing CPSC Authority and Discretion Act of 2011. The Breast Cancer Fund lobbied for a provision that ensures that phthalates, when necessary in the manufacture of children's toys, are only used safely. H.R. 3067: Accelerating the End of Breast Cancer Act of 2011. The Breast Cancer Fund supported this legislation as it would increase focus on research to prevent, treat, and end breast caner. S. 3237, the Accelerating the End of Breast Cancer Act of 2012. The Breast Cancer Fund supports this legislation as it would increase focus on research to prevent, treat, and end breast cancer. House and Senate Appropriations - The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program, opposing appropriations riders limiting the work of the National Toxicology Program's Report on Carcinogens, and increasing support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various House and Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. Presidents Cancer Panel Report The Breast Cancer Fund communicated with staff in the Executive Office of the President and the Office of Science and Technology Policy regarding the report and recommendations of the President's Cancer Panel, and continues to encourage ongoing efforts by the Executive Branch to raise awareness about breast cancer risk, prevention, and the environment. P.L. 110-314 - The Consumer Product Safety Commission Inprovement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of children's toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and are submitting public comments at various stages of the law's implementation. P.L. 110-354 - Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.
Endocrine-Disrupting Chemicals Exposure Elimination Act of 2011
Client: BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) · Firm: THE RABEN GROUP
Legislation in the 112th H.R. 432, the Ban Poisonous Additives Act of 2011( related Senate Bill, S. 136) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. Continued: Legislation in the 112th S. 847, the Safe Chemicals Act of 2011 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 2359, the Safe Cosmetics Act of 2011 The Breast Cancer Fund supports this legislation to reform the FDA's regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. H.R.4395, the Cosmetic Safety Amendments Act of 2012 The Breast Cancer Fund opposes this legislation as it would further weaken the FDAs ability to regulate the safety of cosmetics. H.R. 4262, the Cosmetics Safety Enhancement Act of 2012 The Breast Cancer Fund opposes this legislation as it is not strong enough to effectively regulate the safety of cosmetics. H.R. 2521, the Endocrine-Disrupting Chemicals Exposure Elimination act of 2011 (Senate version S. 1361) and H.R. 553 Endocrine Disruptor Screening Enhancement Act of 2011 The Breast Cancer Fund supported this legislation as it would increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. H.R. 1939: Enhancing CPSC Authority and Discretion Act of 2011. The Breast Cancer Fund lobbied for a provision that ensures that phthalates, when necessary in the manufacture of children's toys, are only used safely. H.R. 3067: Accelerating the End of Breast Cancer Act of 2011. The Breast Cancer Fund supported this legislation as it would increase focus on research to prevent, treat, and end breast caner. S. 3237, the Accelerating the End of Breast Cancer Act of 2012. The Breast Cancer Fund supports this legislation as it would increase focus on research to prevent, treat, and end breast cancer. House and Senate Appropriations - The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program as well as support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various House and Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. Presidents Cancer Panel Report The Breast Cancer Fund communicated with staff in the Executive Office of the President and the Office of Science and Technology Policy regarding the report and recommendations of the President's Cancer Panel, and continues to encourage ongoing efforts by the Executive Branch to raise awareness about breast cancer risk, prevention, and the environment. P.L. 110-314 - The Consumer Product Safety Commission Inprovement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of children's toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and are submitting public comments at various stages of the law's implementation. P.L. 110-354 - Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Science & Technology Policy (OSTP), SENATE, White House Office
JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE via THE RABEN GROUP
2014 · third_quarter · Q3
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, White House Office
BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) via THE RABEN GROUP
2014 · third_quarter · Q3
Legislation in the 113th Please see additional page for lobbying issues:S. 1009, the Chemical Safety Improvement Act of 2013 The Breast Cancer Fund opposes this legislation in its current form as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 696, the Safe Chemicals Act of 2013 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 1385, the Safe Cosmetics and Personal Care Products Act of 2013 The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the CDCs environmental health grants programs and for NIEHS programs related to breast cancer research. H.R.4435, National Defense Authorization Act for FY2015 (NDAA) The Breast Cancer Fund supports an amendment to NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). S.2410, National Defense Authorization Act for FY2015 (NDAA) The Breast Cancer Fund supports an amendment to NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts.Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation.
Filing targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE
INNOCENCE PROJECT via THE RABEN GROUP
2014 · second_quarter · Q2
Specific lobbying issues: Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. H.R. 3064, the Forensic Science and Standards Act of 2013. S.2022, Forensic Science and Standards Act of 2014. S.2177, Criminal Justice and Forensic Science Reform Act.Advocated for appropriations to support the expansion of forensic science research and standard-setting
Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. H.R. 3064, the Forensic Science and Standards Act of 2013. S.2022, Forensic Science and Standards Act of 2014. S.2177, Criminal Justice and Forensic Science Reform Act.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Science & Technology Policy (OSTP), SENATE, White House Office
JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE via THE RABEN GROUP
2014 · second_quarter · Q2
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, White House Office
BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) via THE RABEN GROUP
2014 · second_quarter · Q2
Legislation in the 113th Please see additional page for lobbying issues:S. 1009, the Chemical Safety Improvement Act of 2013 The Breast Cancer Fund opposes this legislation in its current form as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 696, the Safe Chemicals Act of 2013 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 1385, the Safe Cosmetics and Personal Care Products Act of 2013 The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the CDCs environmental health grants programs and for NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation.
JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE via THE RABEN GROUP
2014 · first_quarter · Q1
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) via THE RABEN GROUP
2014 · first_quarter · Q1
Legislation in the 113th Please see additional page for lobbying issues:S. 1009, the Chemical Safety Improvement Act of 2013 The Breast Cancer Fund opposes this legislation in its current form as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 696, the Safe Chemicals Act of 2013 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 1385, the Safe Cosmetics and Personal Care Products Act of 2013 The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the CDCs environmental health grants programs and for NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation.
INNOCENCE PROJECT via THE RABEN GROUP
2014 · first_quarter · Q1
Specific lobbying issues: Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. H.R. 3064, the Forensic Science and Standards Act of 2013. S.2022, Forensic Science and Standards Act of 2014. S.2177, Criminal Justice and Forensic Science Reform Act.Advocated for appropriations to support the expansion of forensic science research and standard-setting
Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. H.R. 3064, the Forensic Science and Standards Act of 2013. S.2022, Forensic Science and Standards Act of 2014. S.2177, Criminal Justice and Forensic Science Reform Act.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Science & Technology Policy (OSTP), SENATE, White House Office
INNOCENCE PROJECT via THE RABEN GROUP
2013 · fourth_quarter · Q4
Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. Advocated for appropriations to support the expansion of forensic science research and standard-setting.
Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. H.R. 3064, the Forensic Science and Standards Act of 2013.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Science & Technology Policy (OSTP), SENATE, White House Office
JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE via THE RABEN GROUP
2013 · fourth_quarter · Q4
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) via THE RABEN GROUP
2013 · fourth_quarter · Q4
Legislation in the 113th Please see additional page for lobbying issues:S. 1009, the Chemical Safety Improvement Act of 2013 The Breast Cancer Fund opposes this legislation in its current form as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 696, the Safe Chemicals Act of 2013 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 1385, the Safe Cosmetics and Personal Care Products Act of 2013 The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program, and increasing support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation.
INNOCENCE PROJECT via THE RABEN GROUP
2013 · third_quarter · Q3
Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. Advocated for appropriations to support the expansion of forensic science research and standard-setting.
Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. H.R. 3064, the Forensic Science and Standards Act of 2013.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Science & Technology Policy (OSTP), SENATE, White House Office
JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE via THE RABEN GROUP
2013 · third_quarter · Q3
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) via THE RABEN GROUP
2013 · third_quarter · Q3
Legislation in the 113th Please see additional page for lobbying issues:S. 1009, the Chemical Safety Improvement Act of 2013 The Breast Cancer Fund opposes this legislation in its current form as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 696, the Safe Chemicals Act of 2013 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 1385, the Safe Cosmetics and Personal Care Products Act of 2013 The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program, and increasing support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation.
BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) via THE RABEN GROUP
2013 · second_quarter · Q2
Legislation in the 113th Please see additional page for lobbying issues:S. 696, the Safe Chemicals Act of 2013 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 1385, the Safe Cosmetics and Personal Care Products Act of 2013 The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program, and increasing support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation.
INNOCENCE PROJECT via THE RABEN GROUP
2013 · second_quarter · Q2
Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. Advocated for appropriations to support the expansion of forensic science research and standard-setting.
Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Science & Technology Policy (OSTP), SENATE, White House Office
JOBS WITH JUSTICE ON BEHALF OF NATIONAL DOMESTIC WORKERS ALLIANCE via THE RABEN GROUP
2013 · second_quarter · Q2
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
INNOCENCE PROJECT via THE RABEN GROUP
2013 · first_quarter · Q1
Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. The Criminal Justice and Forensic Science Reform Act of 2011, S.132. The Forensic Science and Standards Act of 2012, S.3378/H.R.6106.
Conducted outreach regarding the need for forensic science reform, including the potential establishment of a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Science & Technology Policy (OSTP), SENATE, White House Office
BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) via THE RABEN GROUP
2013 · first_quarter · Q1
Legislation in the 113th Please see additional page for lobbying issues:S. 696, the Safe Chemicals Act of 2013 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 1385, the Safe Cosmetics and Personal Care Products Act of 2013 The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program, and increasing support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation.
BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) via THE RABEN GROUP
2012 · fourth_quarter · Q4
Legislation in the 112th H.R. 432, the Ban Poisonous Additives Act of 2011( related Senate Bill, S. 136) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. Continued: Legislation in the 112th S. 847, the Safe Chemicals Act of 2011 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 2359, the Safe Cosmetics Act of 2011 The Breast Cancer Fund supports this legislation to reform the FDA's regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. H.R.4395, the Cosmetic Safety Amendments Act of 2012 The Breast Cancer Fund opposes this legislation as it would further weaken the FDAs ability to regulate the safety of cosmetics. H.R. 4262, the Cosmetics Safety Enhancement Act of 2012 The Breast Cancer Fund opposes this legislation as it is not strong enough to effectively regulate the safety of cosmetics. H.R. 2521, the Endocrine-Disrupting Chemicals Exposure Elimination act of 2011 (Senate version S. 1361) and H.R. 553 Endocrine Disruptor Screening Enhancement Act of 2011 The Breast Cancer Fund supported this legislation as it would increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. H.R. 1939: Enhancing CPSC Authority and Discretion Act of 2011. The Breast Cancer Fund lobbied for a provision that ensures that phthalates, when necessary in the manufacture of children's toys, are only used safely. H.R. 3067: Accelerating the End of Breast Cancer Act of 2011. The Breast Cancer Fund supported this legislation as it would increase focus on research to prevent, treat, and end breast caner. S. 3237, the Accelerating the End of Breast Cancer Act of 2012. The Breast Cancer Fund supports this legislation as it would increase focus on research to prevent, treat, and end breast cancer. House and Senate Appropriations - The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program, opposing appropriations riders limiting the work of the National Toxicology Program's Report on Carcinogens, and increasing support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various House and Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. Presidents Cancer Panel Report The Breast Cancer Fund communicated with staff in the Executive Office of the President and the Office of Science and Technology Policy regarding the report and recommendations of the President's Cancer Panel, and continues to encourage ongoing efforts by the Executive Branch to raise awareness about breast cancer risk, prevention, and the environment. P.L. 110-314 - The Consumer Product Safety Commission Inprovement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of children's toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and are submitting public comments at various stages of the law's implementation. P.L. 110-354 - Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.
BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) via THE RABEN GROUP
2012 · third_quarter · Q3
Legislation in the 112th H.R. 432, the Ban Poisonous Additives Act of 2011( related Senate Bill, S. 136) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. Continued: Legislation in the 112th S. 847, the Safe Chemicals Act of 2011 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 2359, the Safe Cosmetics Act of 2011 The Breast Cancer Fund supports this legislation to reform the FDA's regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. H.R.4395, the Cosmetic Safety Amendments Act of 2012 The Breast Cancer Fund opposes this legislation as it would further weaken the FDAs ability to regulate the safety of cosmetics. H.R. 4262, the Cosmetics Safety Enhancement Act of 2012 The Breast Cancer Fund opposes this legislation as it is not strong enough to effectively regulate the safety of cosmetics. H.R. 2521, the Endocrine-Disrupting Chemicals Exposure Elimination act of 2011 (Senate version S. 1361) and H.R. 553 Endocrine Disruptor Screening Enhancement Act of 2011 The Breast Cancer Fund supported this legislation as it would increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. H.R. 1939: Enhancing CPSC Authority and Discretion Act of 2011. The Breast Cancer Fund lobbied for a provision that ensures that phthalates, when necessary in the manufacture of children's toys, are only used safely. H.R. 3067: Accelerating the End of Breast Cancer Act of 2011. The Breast Cancer Fund supported this legislation as it would increase focus on research to prevent, treat, and end breast caner. S. 3237, the Accelerating the End of Breast Cancer Act of 2012. The Breast Cancer Fund supports this legislation as it would increase focus on research to prevent, treat, and end breast cancer. House and Senate Appropriations - The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program, opposing appropriations riders limiting the work of the National Toxicology Program's Report on Carcinogens, and increasing support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various House and Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. Presidents Cancer Panel Report The Breast Cancer Fund communicated with staff in the Executive Office of the President and the Office of Science and Technology Policy regarding the report and recommendations of the President's Cancer Panel, and continues to encourage ongoing efforts by the Executive Branch to raise awareness about breast cancer risk, prevention, and the environment. P.L. 110-314 - The Consumer Product Safety Commission Inprovement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of children's toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and are submitting public comments at various stages of the law's implementation. P.L. 110-354 - Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.
AMERICAN SOCIETY OF CRIMINOLOGY via THE RABEN GROUP
2012 · third_quarter · 3@
Supported increased federal funding for science-based research on criminal justice issues.
S. 306, In support of establishing a criminal justice commission. No House bill introduced yet. Education of policymakers about the importance of independent science-based research to criminal justice policymaking.
Filing targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Justice Program, SENATE
ACADEMY OF CRIMINAL JUSTICE SCIENCES via THE RABEN GROUP
2012 · second_quarter · 2@
S. 306, In support of establishing a criminal justice commission. No House bill introduced yet. Education of policymakers about the importance of independent science-based research to criminal justice policymaking.
Supported increased federal funding for science-based research on criminal justice issues, specifically through the DOJ Office of Justice Programs.
Filing targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Justice Program, SENATE
BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) via THE RABEN GROUP
2012 · second_quarter · Q2
Legislation in the 112th H.R. 432, the Ban Poisonous Additives Act of 2011( related Senate Bill, S. 136) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. Continued: Legislation in the 112th S. 847, the Safe Chemicals Act of 2011 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 2359, the Safe Cosmetics Act of 2011 The Breast Cancer Fund supports this legislation to reform the FDA's regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. H.R.4395, the Cosmetic Safety Amendments Act of 2012 The Breast Cancer Fund opposes this legislation as it would further weaken the FDAs ability to regulate the safety of cosmetics. H.R. 4262, the Cosmetics Safety Enhancement Act of 2012 The Breast Cancer Fund opposes this legislation as it is not strong enough to effectively regulate the safety of cosmetics. H.R. 2521, the Endocrine-Disrupting Chemicals Exposure Elimination act of 2011 (Senate version S. 1361) and H.R. 553 Endocrine Disruptor Screening Enhancement Act of 2011 The Breast Cancer Fund supported this legislation as it would increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. H.R. 1939: Enhancing CPSC Authority and Discretion Act of 2011. The Breast Cancer Fund lobbied for a provision that ensures that phthalates, when necessary in the manufacture of children's toys, are only used safely. H.R. 3067: Accelerating the End of Breast Cancer Act of 2011. The Breast Cancer Fund supported this legislation as it would increase focus on research to prevent, treat, and end breast caner. S. 3237, the Accelerating the End of Breast Cancer Act of 2012. The Breast Cancer Fund supports this legislation as it would increase focus on research to prevent, treat, and end breast cancer. House and Senate Appropriations - The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program as well as support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various House and Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. Presidents Cancer Panel Report The Breast Cancer Fund communicated with staff in the Executive Office of the President and the Office of Science and Technology Policy regarding the report and recommendations of the President's Cancer Panel, and continues to encourage ongoing efforts by the Executive Branch to raise awareness about breast cancer risk, prevention, and the environment. P.L. 110-314 - The Consumer Product Safety Commission Inprovement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of children's toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and are submitting public comments at various stages of the law's implementation. P.L. 110-354 - Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.
AMERICAN SOCIETY OF CRIMINOLOGY via THE RABEN GROUP
2012 · second_quarter · Q2
Supported increased federal funding for science-based research on criminal justice issues.
S. 306, In support of establishing a criminal justice commission. No House bill introduced yet. Education of policymakers about the importance of independent science-based research to criminal justice policymaking.
Filing targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Justice Program, SENATE
ACADEMY OF CRIMINAL JUSTICE SCIENCES via THE RABEN GROUP
2012 · second_quarter · Q2
S. 306, In support of establishing a criminal justice commission. No House bill introduced yet. Education of policymakers about the importance of independent science-based research to criminal justice policymaking.
Supported increased federal funding for science-based research on criminal justice issues, specifically through the DOJ Office of Justice Programs.
Filing targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Justice Program, SENATE
HORIZONS FOR HOMELESS CHILDREN via THE RABEN GROUP
2012 · first_quarter · 1T
Advocating on childcare, homelessness prevention and early education. Increased funding to child care programs to the specific lobbying issue section.
Advocating on childcare, homelessness prevention and early education. Increased funding to child care programs to the specific lobbying issue section.
Advocating on childcare, homelessness prevention and early education. Increased funding to child care programs to the specific lobbying issue section.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) via THE RABEN GROUP
2012 · first_quarter · Q1
Legislation in the 112th H.R. 432, the Ban Poisonous Additives Act of 2011( related Senate Bill, S. 136) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. Continued: Legislation in the 112th S. 847, the Safe Chemicals Act of 2011 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 2359, the Safe Cosmetics Act of 2011 The Breast Cancer Fund supports this legislation to reform the FDA's regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. H.R. 2521, the Endocrine-Disrupting Chemicals Exposure Elimination act of 2011 (Senate version S. 1361) and H.R. 553 Endocrine Disruptor Screening Enhancement Act of 2011 The Breast Cancer Fund supported this legislation as it would increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. H.R. 1939: Enhancing CPSC Authority and Discretion Act of 2011. The Breast Cancer Fund lobbied for a provision that ensures that phthalates, when necessary in the manufacture of children's toys, are only used safely. H.R. 3067: Accelerating the End of Breast Cancer Act of 2011. The Breast Cancer Fund supported this legislation as it would increase focus on research to prevent, treat, and end breast caner. House and Senate Appropriations - The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program as well as support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various House and Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. Presidents Cancer Panel Report The Breast Cancer Fund communicated with staff in the Executive Office of the President and the Office of Science and Technology Policy regarding the report and recommendations of the President's Cancer Panel, and continues to encourage ongoing efforts by the Executive Branch to raise awareness about breast cancer risk, prevention, and the environment. P.L. 110-314 - The Consumer Product Safety Commission Inprovement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of children's toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and are submitting public comments at various stages of the law's implementation. P.L. 110-354 - Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.
AMERICAN SOCIETY OF CRIMINOLOGY via THE RABEN GROUP
2012 · first_quarter · Q1
Supported increased federal funding for science-based research on criminal justice issues.
S. 306, In support of establishing a criminal justice commission. No House bill introduced yet. Education of policymakers about the importance of independent science-based research to criminal justice policymaking.
Filing targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Justice Program, SENATE
ACADEMY OF CRIMINAL JUSTICE SCIENCES via THE RABEN GROUP
2012 · first_quarter · Q1
Supported increased federal funding for science-based research on criminal justice issues, specifically through the DOJ Office of Justice Programs.
S. 306, In support of establishing a criminal justice commission. No House bill introduced yet. Education of policymakers about the importance of independent science-based research to criminal justice policymaking.
Filing targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Justice Program, SENATE
HORIZONS FOR HOMELESS CHILDREN via THE RABEN GROUP
2011 · fourth_quarter · Q4
Advocating on childcare, homelessness prevention and early education. Increased funding to child care programs to the specific lobbying issue section.
Advocating on childcare, homelessness prevention and early education. Increased funding to child care programs to the specific lobbying issue section.
Advocating on childcare, homelessness prevention and early education. Increased funding to child care programs to the specific lobbying issue section.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) via THE RABEN GROUP
2011 · fourth_quarter · Q4
Legislation in the 112th H.R. 432, the Ban Poisonous Additives Act of 2011( related Senate Bill, S. 136) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. Continued: Legislation in the 112th S. 847, the Safe Chemicals Act of 2011 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 2359, the Safe Cosmetics Act of 2011 The Breast Cancer Fund supports this legislation to reform the FDA's regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. H.R. 2521, the Endocrine-Disrupting Chemicals Exposure Elimination act of 2011 (Senate version S. 1361) and H.R. 553 Endocrine Disruptor Screening Enhancement Act of 2011 The Breast Cancer Fund supported this legislation as it would increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. H.R. 1939: Enhancing CPSC Authority and Discretion Act of 2011. The Breast Cancer Fund lobbied for a provision that ensures that phthalates, when necessary in the manufacture of children's toys, are only used safely. H.R. 3067: Accelerating the End of Breast Cancer Act of 2011. The Breast Cancer Fund supported this legislation as it would increase focus on research to prevent, treat, and end breast caner. House and Senate Appropriations - The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program as well as support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various House and Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. Presidents Cancer Panel Report The Breast Cancer Fund communicated with staff in the Executive Office of the President and the Office of Science and Technology Policy regarding the report and recommendations of the President's Cancer Panel, and continues to encourage ongoing efforts by the Executive Branch to raise awareness about breast cancer risk, prevention, and the environment. P.L. 110-314 - The Consumer Product Safety Commission Inprovement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of children's toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and are submitting public comments at various stages of the law's implementation. P.L. 110-354 - Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.
HORIZONS FOR HOMELESS CHILDREN via THE RABEN GROUP
2011 · third_quarter · Q3
Advocating on childcare, homelessness prevention and early education. Increased funding to child care programs to the specific lobbying issue section.
Advocating on childcare, homelessness prevention and early education. Increased funding to child care programs to the specific lobbying issue section.
Advocating on childcare, homelessness prevention and early education. Increased funding to child care programs to the specific lobbying issue section.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) via THE RABEN GROUP
2011 · third_quarter · Q3
Legislation in the 112th H.R. 432, the Ban Poisonous Additives Act of 2011( related Senate Bill, S. 136) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. Continued: Legislation in the 112th S. 847, the Safe Chemicals Act of 2011 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 2359, the Safe Cosmetics Act of 2011 The Breast Cancer Fund supports this legislation to reform the FDA's regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. H.R. 2521, the Endocrine-Disrupting Chemicals Exposure Elimination act of 2011 (Senate version S. 1361) and H.R. 553 Endocrine Disruptor Screening Enhancement Act of 2011 The Breast Cancer Fund supported this legislation as it would increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. H.R. 1939: Enhancing CPSC Authority and Discretion Act of 2011. The Breast Cancer Fund lobbied for a provision that ensures that phthalates, when necessary in the manufacture of children's toys, are only used safely. House and Senate Appropriations - The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program as well as support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various House and Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. Presidents Cancer Panel Report The Breast Cancer Fund communicated with staff in the Executive Office of the President and the Office of Science and Technology Policy regarding the report and recommendations of the President's Cancer Panel, and continues to encourage ongoing efforts by the Executive Branch to raise awareness about breast cancer risk, prevention, and the environment. P.L. 110-314 - The Consumer Product Safety Commission Inprovement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of children's toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and are submitting public comments at various stages of the law's implementation. P.L. 110-354 - Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.
BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) via THE RABEN GROUP
2011 · second_quarter · Q2
Legislation in the 112th H.R. 432, the Ban Poisonous Additives Act of 2011( related Senate Bill, S. 136) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. Continued: Legislation in the 112th S. 847, the Safe Chemicals Act of 2011 The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 2359, the Safe Cosmetics Act of 2011 The Breast Cancer Fund supports this legislation to reform the FDA's regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. H.R. 2521, the Endocrine-Disrupting Chemicals Exposure Elimination act of 2011 (Senate version S. 1361) and H.R. 553 Endocrine Disruptor Screening Enhancement Act of 2011 The Breast Cancer Fund supported this legislation as it would increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. H.R. 1939: Enhancing CPSC Authority and Discretion Act of 2011. The Breast Cancer Fund lobbied for a provision that ensures that phthalates, when necessary in the manufacture of children's toys, are only used safely. House and Senate Appropriations - The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program as well as support for health tracking and NIEHS programs related to breast cancer research. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various House and Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. Presidents Cancer Panel Report The Breast Cancer Fund provided educational briefings to staff within the Executive Office of the President and the Office of Science and Technology Policy regarding the report and recommendations of the Presidents Cancer Panel. P.L. 110-314 - The Consumer Product Safety Commission Inprovement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of children's toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and are submitting public comments at various stages of the law's implementation. P.L. 110-354 - Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.
BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) via THE RABEN GROUP
2011 · first_quarter · Q1
Legislation in the 112th H.R. 432, the Ban Poisonous Additives Act of 2011( related Senate Bill, S. 136) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. Continued: Legislation in the 112th House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program as well as support for health tracking and NIEHS programs related to breast cancer research. H.R. 553, Endocrine Disruptor Screening Enhancement Act of 2011. The Breast Cancer Fund supported this legislation as it would increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various House and Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Regulation and Legislative Intent: FDA Advocacy, In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. Presidents Cancer Panel Report, The Breast Cancer Fund provided educational briefings to staff within the Executive Office of the President and the Office of Science and Technology Policy regarding the report and recommendations of the Presidents Cancer Panel. P.L. 110-314, The Consumer Product Safety Commission Improvement Act, The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and are submitting public comments at various stages of the law's implementation. P.L. 110-354, Breast Cancer and Environmental Research Act of 2008, This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.
BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) via THE RABEN GROUP
2010 · fourth_quarter · Q4
Legislation in the 111th H.R. 1523, the Ban Poisonous Additives Act of 2009 (Senate version S. 593) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. Continued: Legislation in the 111th H.R. 2751, FDA Food Safety Modernization Act (Senate version S. 510) The Breast Cancer Fund supported efforts to pass this legislation because of a possible amendment to ban bisphenol-A, a chemical linked to increased rates of cancer, as well as other significant health problems, from certain food contact materials. The Breast Cancer Fund met with staff from various offices to encourage support for this language and eventual passage of the bill. House and Senate Appropriations The Breast Cancer Fund has been speaking with House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program as well as support for health tracking and NIEHS programs related to breast cancer research. H.R. 3057 Household Product Labeling Act of 2009 (Senate version S. 1697) The Breast Cancer Fund supports this legislation because complete and accurate product labeling of chemicals used in consumer products is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. H.R. 4190 Endocrine Disruption Prevention Act of 2009(Senate version S. 2828) The Breast Cancer Fund supports this legislation as it will increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. H.R. 5820 The Safe Chemicals Act of 2010 (Senate version 3209) The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 5786 Safe Cosmetics Act of 2010 (Senate version not yet introduced) The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. Presidents Cancer Panel Report The Breast Cancer Fund provided educational briefings to staff within the Executive Office of the President and the Office of Science and Technology Policy regarding the report and recommendations of the Presidents Cancer Panel. P.L. 110-314 The Consumer Product Safety Commission Improvement Act This law has broadly reformed and modernized the Consumer Product Safety Commission. The Breast Cancer Fund lobbied in support of a Feinstein amendment in the Senate and in conference negotiations which inserts phthalates as a banned substance in the manufacture of childrens toys. We are now monitoring implementation of this law: calling on the Executive Branch to nominate a new Chair for the agency and submitting public comments on various stages of implementation. P.L. 110-354 -- Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.
BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) via THE RABEN GROUP
2010 · third_quarter · Q3
Legislation in the 111th H.R. 1523, the Ban Poisonous Additives Act of 2009 (Senate version S. 593) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. Continued: Legislation in the 111th House and Senate Appropriations The Breast Cancer Fund has been speaking with House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program as well as support for health tracking and NIEHS programs related to breast cancer research. H.R. 3057 Household Product Labeling Act of 2009 (Senate version S. 1697) The Breast Cancer Fund supports this legislation because complete and accurate product labeling of chemicals used in consumer products is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. H.R. 4190 Endocrine Disruption Prevention Act of 2009(Senate version S. 2828) The Breast Cancer Fund supports this legislation as it will increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. H.R. 5820 The Safe Chemicals Act of 2010 (Senate version 3209) The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 5786 Safe Cosmetics Act of 2010 (Senate version not yet introduced) The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. Presidents Cancer Panel Report The Breast Cancer Fund provided educational briefings to staff within the Executive Office of the President and the Office of Science and Technology Policy regarding the report and recommendations of the Presidents Cancer Panel. P.L. 110-314 The Consumer Product Safety Commission Improvement Act This law has broadly reformed and modernized the Consumer Product Safety Commission. The Breast Cancer Fund lobbied in support of a Feinstein amendment in the Senate and in conference negotiations which inserts phthalates as a banned substance in the manufacture of childrens toys. We are now monitoring implementation of this law: calling on the Executive Branch to nominate a new Chair for the agency and submitting public comments on various stages of implementation. P.L. 110-354 -- Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.
Filing targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.Future legislative proposals: Jobs with Justice and its coalition continues to meet with staff in Senate offices to encourage legislative action on the issue of funding to support state innovation in long term services and supports planning and pilot programming.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, White House Office
Filing targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, White House Office
Filing targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, White House Office
Filing targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE
Filing targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
S. Res. 128 Jobs with Justice supports this legislation because it calls for comprehensive reform to supporting seniors and individuals with disabilities as well as expanding and making home care and long-term services affordable and accessible. H. Res. 197 Jobs with Justice supports this legislation because it calls for comprehensive reform in long term care supports to make home care more accessible and affordable for seniors and individuals with disabilities.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, White House Office
Filing targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE
Filing targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE
Filing targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE
Filing targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
Filing targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
Filing targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
Filing targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
Filing targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
Filing targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE
Filing targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE
Filing targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE